The role of vitamin D in cardiovascular disease: From present evidence to future perspectives

2012 ◽  
Vol 225 (2) ◽  
pp. 253-263 ◽  
Author(s):  
Vincent M. Brandenburg ◽  
Marc G. Vervloet ◽  
Nikolaus Marx
Keyword(s):  
Cardiovascular Disease ◽  
Vitamin D ◽  
Future Perspectives ◽  
Present Evidence

The Role of Vitamin D in Dyslipidemia and Cardiovascular Disease

2011 ◽  
Vol 17 (9) ◽  
pp. 933-942 ◽  
Author(s):  
Armin Zittermann ◽  
Jan F. Gummert ◽  
Jochen Borgermann
Keyword(s):  
Cardiovascular Disease ◽  
Vitamin D

Role of vitamin D deficiency in cardiovascular disease

Heart ◽  
2012 ◽  
Vol 98 (8) ◽  
pp. 609-614 ◽  
Author(s):  
Ian R Reid ◽  
Mark J Bolland
Keyword(s):  
Cardiovascular Disease ◽  
Vitamin D ◽  
Vitamin D Deficiency

scholarly journals World endocrinology news

2008 ◽  
Vol 5 (2) ◽  
pp. 45-54
Author(s):  
M A Berkovskaya
Keyword(s):  
Insulin Resistance ◽  
Cardiovascular Disease ◽  
Metabolic Syndrome ◽  
Vitamin D ◽  
Glucose Metabolism ◽  
Oral Cancer ◽  
Fat Distribution ◽  
Lower Prevalence ◽  
The Metabolic Syndrome

The role of interleukin-6 in insulin resistance, body fat distribution and energy balance Disorders of glucose metabolism and risk of oral cancer. Duration of lactation is associated with lower prevalence of the metabolic syndrome in midlife--SWAN, the study of women's health across the nation. Vitamin D deficiency and risk of cardiovascular disease. Adypocyte prolactin: regulation of release and putative functions.

Therapeutic Role of Vitamin D in Cardiovascular Disease: Emerging Evidence

2018 ◽  
Vol 07 (02) ◽  
Author(s):  
Moretti HD ◽  
Grant WB ◽  
Berry BD ◽  
Colucci VJ
Keyword(s):  
Cardiovascular Disease ◽  
Vitamin D ◽  
Therapeutic Role

scholarly journals Optimal Vitamin D Supplementation Levels for Cardiovascular Disease Protection

2015 ◽  
Vol 2015 ◽  
pp. 1-10 ◽  
Author(s):  
Sebastian T. Lugg ◽  
Phillip A. Howells ◽  
David R. Thickett
Keyword(s):  
Cardiovascular Disease ◽  
Vitamin D ◽  
Current Knowledge ◽  
Experimental Studies ◽  
Vitamin D Supplementation ◽  
Disease Marker ◽  
Vitamin D Levels ◽  
Artery Disease ◽  
Randomised Controlled

First described in relation to musculoskeletal disease, there is accumulating data to suggest that vitamin D may play an important role in cardiovascular disease (CVD). In this review we aim to provide an overview of the role of vitamin D status as both a marker of and potentially causative agent of hypertension, coronary artery disease, heart failure, atrial fibrillation, stroke, and peripheral vascular disease. The role of vitamin D levels as a disease marker for all-cause mortality is also discussed. We review the current knowledge gathered from experimental studies, observational studies, randomised controlled trials, and subsequent systematic reviews in order to suggest the optimal vitamin D level for CVD protection.

The role of vitamin D deficiency in cardiovascular disease: where do we stand in 2013?

2013 ◽  
Vol 87 (12) ◽  
pp. 2083-2103 ◽  
Author(s):  
Stefan Pilz ◽  
Martin Gaksch ◽  
Bríain O’Hartaigh ◽  
Andreas Tomaschitz ◽  
Winfried März
Keyword(s):  
Cardiovascular Disease ◽  
Vitamin D ◽  
Vitamin D Deficiency

scholarly journals Systemic Role for Vitamin D in the Treatment of Psoriasis and Metabolic Syndrome

2011 ◽  
Vol 2011 ◽  
pp. 1-4 ◽  
Author(s):  
Lisa Wenyang Fu ◽  
Ronald Vender
Keyword(s):  
Cardiovascular Disease ◽  
Metabolic Syndrome ◽  
Vitamin D ◽  
Inflammatory Diseases ◽  
Systemic Disease ◽  
The Novel ◽  
Oral Vitamin ◽  
Potential Use

The novel discovery of the systemic role of vitamin D in the modulation of the immune system especially the Type 1 helper T cell (Th1) pathway reveals its potential for treating Th1 inflammatory diseases. Psoriasis has been recently established to be a systemic disease centered on inflammation and involvement of cytokines of the Th1 pathway. There is an increased prevalence of metabolic syndrome in patients with psoriasis. Metabolic syndrome also involves a proinflammatory state. This paper proposes the idea of the potential use of oral vitamin D to treat psoriasis and metabolic syndrome concurrently. We propose there is merit in more clinical trials investigating the use of vitamin D to treat both psoriasis and metabolic syndrome through its anti-inflammatory effects. On application to psoriasis management and prognosis, the goal is to decrease the risk for cardiovascular disease and decrease disease morbidity and mortality.

Sign in / Sign up

Export Citation Format

Share Document